Literature DB >> 20212477

Oversulfated chondroitin sulfate is not the sole contaminant in heparin.

Jing Pan, Yi Qian, Xiaodong Zhou, Andrew Pazandak, Sarah B Frazier, Peter Weiser, Hong Lu, Lijuan Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20212477     DOI： 10.1038/nbt0310-203

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  19 in total

1.  Contaminants in heparins continue to be unfolded.

Authors:  J Fareed; M Ahluwalia; R Wahi; E Ramaccioti; D Hoppensteadt; R L Bick
Journal:  Int Angiol       Date:  2008-12       Impact factor: 2.789

Review 2.  Danaparoid sodium.

Authors:  J M Acostamadiedo; U G Iyer; J Owen
Journal:  Expert Opin Pharmacother       Date:  2000-05       Impact factor: 3.889

3.  Preparation and anticoagulant activity of fully O-sulphonated glycosaminoglycans.

Authors:  T Toida; T Maruyama; Y Ogita; A Suzuki; H Toyoda; T Imanari; R J Linhardt
Journal:  Int J Biol Macromol       Date:  1999-12-01       Impact factor: 6.953

4.  Purification of heparin, dermatan sulfate and chondroitin sulfate from mixtures by sequential precipitation with various organic solvents.

Authors:  N Volpi
Journal:  J Chromatogr B Biomed Appl       Date:  1996-10-11

5.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

Review 6.  Heparin-induced thrombocytopenia: impact of bovine versus porcine heparin in HIT pathogenesis.

Authors:  Sarfraz Ahmad
Journal:  Front Biosci       Date:  2007-05-01

7.  Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.

Authors:  Zhenqing Zhang; Boyangzi Li; Jiraporn Suwan; Fuming Zhang; Zhenyu Wang; Haiying Liu; Barbara Mulloy; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

8.  Orthogonal analytical approaches to detect potential contaminants in heparin.

Authors:  Marco Guerrini; Zhenqing Zhang; Zachary Shriver; Annamaria Naggi; Sayaka Masuko; Robert Langer; Benito Casu; Robert J Linhardt; Giangiacomo Torri; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

Review 9.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

10.  Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.

Authors:  P Hovingh; M Piepkorn; A Linker
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857
View more
  12 in total

1.  Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.

Authors:  Sukhbir Kaur; Svetlana A Kuznetsova; Michael L Pendrak; John M Sipes; Martin J Romeo; Zhuqing Li; Lijuan Zhang; David D Roberts
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

2.  Synthesis of 3-O-Sulfated Disaccharide and Tetrasaccharide Standards for Compositional Analysis of Heparan Sulfate.

Authors:  Vijay Manohar Dhurandhare; Vijayakanth Pagadala; Andreia Ferreira; Louis De Muynck; Jian Liu
Journal:  Biochemistry       Date:  2019-10-23       Impact factor: 3.162

3.  Mass balance analysis of contaminated heparin product.

Authors:  Zhenling Liu; Zhongping Xiao; Sayaka Masuko; Wenjing Zhao; Eric Sterner; Vinod Bansal; Jawed Fareed; Jonathan Dordick; Fuming Zhang; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

4.  Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways.

Authors:  Jing Pan; Yi Qian; Xiaodong Zhou; Hong Lu; Eduardo Ramacciotti; Lijuan Zhang
Journal:  J Biol Chem       Date:  2010-04-23       Impact factor: 5.157

5.  Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin.

Authors:  Jong Youn Baik; Leyla Gasimli; Bo Yang; Payel Datta; Fuming Zhang; Charles A Glass; Jeffrey D Esko; Robert J Linhardt; Susan T Sharfstein
Journal:  Metab Eng       Date:  2012-02-06       Impact factor: 9.783

Review 6.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

Review 7.  Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician.

Authors:  Connie N Hess; Richard C Becker; John H Alexander; Renato D Lopes
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

8.  Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Chao Cai; Lingyun Li; Li Fu; Yuqing Chang; Fuming Zhang; Toshihiko Toida; Changhu Xue; Robert J Linhardt
Journal:  Anal Chem       Date:  2013-12-23       Impact factor: 6.986

9.  Glycosaminoglycan-mediated selective changes in the aggregation states, zeta potentials, and intrinsic stability of liposomes.

Authors:  Erin K Nyren-Erickson; Manas K Haldar; Jessica R Totzauer; Riley Ceglowski; Dilipkumar S Patel; Daniel L Friesner; D K Srivastava; Sanku Mallik
Journal:  Langmuir       Date:  2012-11-07       Impact factor: 3.882

10.  A new approach for heparin standardization: combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis.

Authors:  Marcelo A Lima; Timothy R Rudd; Eduardo H C de Farias; Lyvia F Ebner; Tarsis F Gesteira; Lauro M de Souza; Aline Mendes; Carolina R Córdula; João R M Martins; Debra Hoppensteadt; Jawed Fareed; Guilherme L Sassaki; Edwin A Yates; Ivarne L S Tersariol; Helena B Nader
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.